Coagulative safety of epidural catheters after major upper gastrointestinal surgery: advanced and routine coagulation analysis in 38 patients by unknown
RESEARCH Open Access
Coagulative safety of epidural catheters
after major upper gastrointestinal surgery:
advanced and routine coagulation analysis
in 38 patients
Owain Thomas1,2* , Hampus Rein5, Karin Strandberg1,3 and Ulf Schött1,4
Abstract
Background: The risk of spinal haematoma in patients receiving epidural catheters is estimated using routine
coagulation tests, but guidelines are inconsistent in their recommendations on what to do when results indicate
slight hypocoagulation. Postoperative patients are prone to thrombosis, and thromboelastometry has previously
shown hypercoagulation in this setting. We aimed to better understand perioperative haemostasis by comparing
results from routine and advanced tests, hypothesizing that patients undergoing major upper gastrointestinal
surgery would be deficient in vitamin K-dependent coagulation factors because of malnutrition, or hypocoagulative
because of accumulation of low molecular weight heparin (LMWH).
Methods: Thirty-eight patients receiving epidural analgesia for major upper gastrointestinal surgery were
included. We took blood at the time of preoperative epidural catheterization and at catheter withdrawal.
Prothrombin time-international normalized ratio (PT-INR), activated partial thromboplastin time (aPTT) and
platelet count (Plc) were analysed, and also albumin, proteins induced by vitamin K absence (PIVKA-II),
rotational thromboelastometry (ROTEM®), multiple electrode aggregometry (Multiplate®) and activities of
factors II, VII, IX, X, XI, XII and XIII.
Results: Postoperative coagulation was characterized by thrombocytosis and hyperfibrinogenaemia. Mean PT-INR
increased significantly from 1.0 ± 0.1 to 1.2 ± 0.2 and mean aPTT increased significantly from 27 ± 3 to 30 ± 4 s. Activity
of vitamin K-dependent factors did not decrease significantly: FIX and FX activity increased. FXII and FXIII decreased
significantly. Mean Plc increased from 213 ± 153 × 106/L while all mean ROTEM-MCFs (maximal clot firmnesses)
especially FIBTEM-MCF increased significantly to above the reference interval. All mean ROTEM® clotting times were
within their reference intervals both before and after surgery. ROTEM® (HEPTEM minus INTEM) results were spread
around 0. There were significant correlations between routine tests and the expected coagulation factors, but not any
of the viscoelastic parameters or PIVKA-II. Multiplate® area under curve and EXTEM-MCF correlated significantly to Plc
as did EXTEM-MCF to fibrinogen, FIX, FX and FXIII; and FIBTEM-MCF to Plc, FII, FXI and FXIII.
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Conclusions: The increase in PT-INR may be caused by decreased postoperative FVII while the elevated aPTT may be
caused by low FXII. The mild postoperative hypocoagulation indicated by routine tests is not consistent with
thromboelastometry. The relevance of ROTEM® and Multiplate® in the context of moderately increased routine tests
remains unclear.
Trial registration number is not applicable since this is not a clinical trial.
Keywords: Blood coagulation factors, International normalized ratio, Partial thromboplastin time, Thromboelastometry,
Platelet aggregation, Epidural analgesia, Postoperative complications, Hematoma, Safety
Background
Epidural anaesthesia is used extensively in modern prac-
tice and likely decreases morbidity and mortality after
major surgery involving thoracotomy (van Lier et al.
2011). Neurological damage due to haemorrhage in the
spinal canal is rare but well-described (De Tommaso et
al. 2002; Horlocker et al. 2010a) and is most likely to
occur at the times of insertion and removal of epidural
catheters, when the incidences are estimated to be
1:4000–1:30,000 and 1:150,000–1:190,000 (Moen et al.
2004; Miyazaki et al. 2005; Pace et al. 2014). Certain
types of patients are at greater risk of spinal haematoma
than others: elderly women undergoing orthopaedic sur-
gery are at particularly high risk (Moen et al. 2004).
Coagulative deficits are often noted after major surgery
(Anveden et al. 2010) and increase the risk of spinal
haematoma, which may be caused by loss of coagulation
factors (F) and platelets due to haemorrhage, systemic
inflammation, disseminated intravascular coagulation
(DIC), preoperative malnutrition, accumulation of
thrombosis prophylaxis or deficiency of vitamin K due
to prolonged antibiotic treatment (van Lier et al. 2011;
Gogarten et al. 2010). Routine tests of coagulation
such as prothrombin time-international normalized
ratio (PT-INR), activated partial thromboplastin time
(aPTT) and platelet count (Plc) are unreliable predic-
tors of perioperative bleeding, and their usefulness in
assessing the risk of spinal haemorrhage in the con-
text of epidural catheterization is limited (Ganter and
Hofer 2008; Breivik et al. 2010; Chee et al. 2008).
Although many authors stress the importance of
coagulation monitoring, both before inserting and epi-
dural catheter and when the catheter needs to be re-
moved, current international guidelines are vague
concerning what constitutes a coagulation deficit and
how these should be treated: both the European and
American guidelines are primarily concerned with
drug-induced hypocoagulation rather than spontan-
eously occurring deficits of coagulation (Davignon et
al. 2008): Additional file 1 summarizes these (Gogar-
ten et al. 2010; Breivik et al. 2010). A strategy
employed at our institution when an epidural catheter
is due for removal but aPTT or PT-INR are elevated,
is postponement of treatment with low molecular
weight heparins (LMWHs), administration of intra-
venous vitamin K and renewed testing the following
day. Some recommend whole-blood tests such as
viscoelasticity and platelet aggregometry (for example
rotational thromboelastometry (ROTEM®) and Multi-
plate®), but how these complement routine tests and
how to interpret inconsistencies between routine and
whole-blood tests is unclear (Breivik et al. 2010;
Thomas et al. 2013; Tanaka and Dietrich 2011).
The aim of our study was to describe and compare
patterns in routine coagulation tests, thromboelasto-
metry and platelet aggregation, coagulation factor
activity and levels of PIVKA (proteins induced by
vitamin K absence) before and after major surgery, to
better understand how these tests reflect perioperative
coagulation in the specific context of epidural
catheterization. We hypothesized that preoperative
malnutrition in patients with upper gastrointestinal
pathology would lead to a depletion of vitamin
K-dependent coagulation factors. Thereby, we hoped
to be able to evaluate the appropriateness of the
above described clinical strategy used when an
epidural catheter is to be withdrawn in a patient with
abnormal routine coagulation test results. We also
hypothesized that thromboelastometry with a hepari-
nase reagent (HEPTEM®) would indicate an accumu-
lation of LMWH due to postoperative renal failure
combined with thrombosis prophylaxis.
Methods
Participants
Thirty-eight patients were included in the study over a
total period of 8 months in 2013 and 2014. Included in
the study were patients scheduled for general anaesthe-
sia and epidural analgesia for major upper gastrointes-
tinal surgery but not liver resection. Patients completed
a preoperative questionnaire covering general health,
nutrition and medication, bleeding history and risk of
haemorrhage. Those with deranged preoperative coagu-
lation parameters, i.e. low blood Plc, increased PT-INR
or prolonged aPTT, and those receiving therapeutic
doses of LMWH were not included.
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Blood sampling
See Table 1 and Additional file 2 for a summary of the
tests analysed and reagents used.
Preoperative blood samples were taken immediately after
placement of an arterial catheter in the operating room.
Postoperative blood samples were taken on the surgical
ward, from patients’ central venous catheters within 4 h of
withdrawal of the patient’s epidural catheter when it was
withdrawn as part of the patient’s routine care. Patients’
central venous catheters were not heparinized.
Routine analyses were run at our hospital’s Department
of Clinical Chemistry, which is accredited by SWEDAC
(Borås, Sweden). The following sampling tubes were filled
on each occasion: one 4.5-mL citrate tube (0.129 M cit-
rate, BD Vacutainer® systems, Plymouth, UK) for routine
PT-INR, aPTT, fibrinogen and D-dimer; one 3-mL EDTA
tube (K2EDTA, BD Vacutainer® systems, Plymouth, UK)
for routine platelet count; one 3-mL lithium-heparin tube
(LH PST, BD Vacutainer® systems, Plymouth, UK) for rou-
tine alkaline phosphatase (ALP), C-reactive protein (CRP),
gamma-glutamyltransferase (GT) and creatinine; one
3-mL hirudinated blood tube for whole-blood multiple
electrode platelet aggregometry (Multiplate®) at 37 °C
according to the manufacturer’s instructions, at our
patient-near laboratory approximately 30 min after sam-
pling; one 1-mL heparinized syringe for ‘blood gas ana-
lysis’ including haemoglobin (Hb) (PICO 50, Radiometer
medical ApS, Brønshøj, Denmark); two additional citrate
tubes (3.2 % citrate, BD Vacutainer® systems, Plymouth,
UK) for thromboelastometry using four reagents at 37 °C
within 2 h of sampling, and for centrifugation at 2000
revolutions/min (rpm) for 20 min (Hettich Zentrifugen,
78532 Tuttlingen, Germany). Batches of 500 μL of
the resultant plasma were pipetted into six micro
tubes (Finnpipette™, Thermo Electron Corporation 1.5 mL,
Sarstedt, Nümbrecht, Germany) and frozen to −80 °C
awaiting analysis of coagulation factors and PIVKA-II in a
batch at the coagulation laboratory. The following factors’
activities were determined with a clot-based one-stage
method: FII, FVII, FIX, FX, FXI, FXII and FXIII.
Markers of malnutrition
The plasma concentration of PIVKA-II was determined.
PIVKA-II is hypocarboxylated prothrombin produced
when there is a deficiency of vitamin K (Dituri et al.
2012). Each test was run in duplicate and the mean of
the results used. Patients’ preoperative serum albumin
was recorded from their notes.
Statistical analysis
Primary data was compiled in a Microsoft® Excel spread-
sheet then exported to the R statistics package (version
3.0.3, www.r-project.org) for analysis. See Additional file 3.
Mean vales are presented as mean ± standard deviation.
Wilcoxon’s signed ranked test for paired samples was
used to determine the significance (p < 0.05) of differ-
ences between pre- and postoperative variables. Pear-
son’s (parametric) product–moment and Spearman’s
(non-parametric) rank correlation test were used to calcu-
late the significance of correlations between parameters.
Two tests of correlation were used because non-
parametric tests are more suitable for this rather small
data set, but since PT-INR results are recorded to the
nearest 0.1 units, there were many tied results making
non-parametric tests using ranks unreliable. Correlations
are presented as scatter graphs while original data are
presented as boxplots and tables.
Table 1 Assays taken and reference intervals
Parameter Reference interval
ROTEM EXTEM-MCF (maximal clot firmness) 50–72 mm
ROTEM EXTEM-CT (clotting time) 38–79 mm
ROTEM INTEM-MCF 50–72 mm
ROTEM INTEM-CT 100–240 s
ROTEM FIBTEM-MCF 9–25 mm
ROTEM HEPTEM-MCF 50–72 mm
ROTEM HEPTEM-CT 100–240 s
Multiplate® AUC (area under curve): ADPtest 57–113 U
Multiplate® AUC: COLtest 72–125 U
Multiplate® AUC: TRAPtest 84–128 U










Platelet count (Plc) Women 165–387
Men 145–348 × 109/L
P-Fibrinogen 2.0–4.0 mg/mL
D-dimer <0.25 mg/L
Gamma-glutamyltransferase (GT) 0.2–1.9 μkat/L
C-reactive protein (CRP) <3.0 mg/L
Bilirubin 5–25 μmol/L
Alkaline phosphatase (ALP) 0.6–1.8μkat/L
Creatinine 45–90 μmol/L
Haemoglobin (Hb) Women 117–153 g/L
Men 134–170
PIVKA-II (protein induced by vitamin K absence) <2.0 mg/L
See Additional file 2 for a technical specification of the apparatuses and
reagents used
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Results
Epidemiological data is shown in Table 2. All the patients
received a thoracic epidural catheter before induction of
anaesthesia and were administered daily thrombosis
prophylaxis in the form of 40 mg of subcutaneous enoxa-
parin (Klexane®, Sanofi) at 8.00 p.m. One of the patients
was postoperatively given enoxaparin in therapeutic doses
of 110 mg twice daily due to postoperative pulmonary
embolism. None of the patients received platelet inhibitors
during the study period; one patient had been anticoagu-
lated with warfarin until 5 days before surgery and one
until 2 months before surgery. Three received ‘bridging’:
during the week before surgery LMWH was given in
prophylactic doses instead of normal ASA or warfarin.
Table 3 shows routine laboratory results. Mean
preoperative serum albumin was at the lower end of the
reference interval and serum creatinine decreased
slightly but significantly over the perioperative course.
Viscoelastic and routine tests of coagulation
See Fig. 1 and Table 3. All ROTEM® parameters’ mean
maximal clot firmnesses (MCFs) were within the refer-
ence interval preoperatively and significantly greater
than the reference interval postoperatively. FIBTEM-
MCF indicated hypercoagulation more than the other
measures. All the mean ROTEM® clotting times (CTs)
were within their reference intervals, and there was
no significant difference between pre- and postopera-
tive results
The distributions of ROTEM® HEPTEM-INTEM CT
and MCF were somewhat surprisingly centred around 0:
results activated with the INTEM reagent and a hepari-
nase often showed hypocoagulability compared to results
from tests activated with the INTEM reagent alone.
Mean PT-INR increased significantly: all of the
patients’ preoperative PT-INR values were within the
reference interval, whereas eight exceeded it postopera-
tively: the maximum PT-INR was 1.6 in a patient whose
epidural was removed on the second postoperative day
after stomach resection. His aPTT was 26 s and PIVKA-
II 12.5 mg/L. Coagulation factor activities for this patient
were within the reference ranges other than FII
(0.55 kIE/L), FXII (0.37 kIE/L) and FXIII (0.58 kIE/L).
Mean aPTT increased significantly over the periopera-
tive course. Still, only five of the patients’ postoperative
aPTT values exceeded the upper reference limit. There
was no correlation between age and postoperative aPTT
nor were there significant correlations between PT-INR or
aPTT and any of the viscoelastic parameters (see Fig. 2).
Platelet results
Mean Plc was significantly higher postoperatively: see
Fig. 3 and Table 3. All the patients whose Plc was signifi-
cantly lower on withdrawal of the epidural catheter than
Table 2 Epidemiological data and indications for surgery
Epidemiological data
Sex 27 males;11 females
Mean age 70.2 ± 6.9 years
(range 57–82 years)
Mean duration of operation 10.4 h
Median perioperative blood loss 400 mL (range 50–4650 mL)
Mean perioperative fluid loss
through surgical drains
430 ± 355 mL
Mean time from epidural
catheterization to withdrawal
6.2 ± 3.2 days (range 2–15)
Included and preoperative tests
taken, but postoperative tests not
taken due to transfer to other
hospital or researcher being absent.
5 patients




















PT-INR 1.0 ± 0.1 1.2 ± 0.2* 0.9–1.1
aPTT (s) 27 ± 3 30 ± 4* 26–33
Plc (× 109/L) 213 ± 153 283 ± 153* 145–387
Fibrinogen (g/L) 3.2 ± 0.9 5.8 ± 1.1 2.0–4.0
CRP (mg/L) 6.8 ± 9.4 92 ± 60 <3.0
D-dimer (mg/L) 0.25 ± 0.22 1.73 ± 1.05 <0.25
Serum albumin (g/L) 36.6 ± 3.7 – 36–45
Serum creatinine
(μmol/L)
73.4 ± 19 65.2 ± 18.3* 45–105
Serum bilirubin
(μmol/L)
14 ± 22 10 ± 16* 5–25
ALP (μkat/L) 1.64 ± 1.1 2.30 ± 1.3* 0.6–1.8
Bilirubin (μmol/L) 14 ± 22 11 ± 16* 5–25
GT (μkat/L) 1.3 ± 2.0 2.1 ± 1.9* 0.2–1.9
Blood haemoglobin
(g/L)
119 ± 16 g/L 113 ± 12 g/L Men 134–170;
women 117–153
Italics indicate results outside the reference interval. Results are presented as
mean ± standard deviation
ALP alkaline phosphatase, GT gamma-glutamyltransferase, PT-INR prothrombin-
international normalized ratio, aPTT activated partial thromboplastin time, Plc
platelet count, CRP C-reactive protein
*Significant difference between pre- and postoperative values (P < 0.05)
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before the operation had their epidural withdrawn on
the third postoperative day or earlier. One patient’s
epidural catheter was accidentally withdrawn when Plc
was 35 × 109/L: see Additional file 4. All mean pre- and
postoperative Multiplate® ADP-AUC (area under curve)
results were within the reference range, correlated
significantly to Plc with a correlation coefficient of 0.6
and increased significantly pre- to postoperatively.
There was a significant correlation between postopera-


























































































Fig. 1 Pre- to postoperative changes in thromboelastometry (ROTEM®) and routine tests of coagulation. PT-INR prothrombin time-international
normalized ratio, aPTT activated partial thromboplastin time. Dashed lines indicate reference intervals, brackets indicate significant differences in
pre- and postoperative results *P < 0.05; **P < 0.01
Fig. 2 Correlations between routine, viscoelastic and advanced tests of coagulation and CRP. Blue: vitamin K-dependent factor. Yellow: significant
correlation. *P < 0.05. **P < 0.01. Dashed line: only one of Spearman and Pearson’s tests is significant, the other is slightly more than P = 0.05
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EXTEM and FIBTEM reagents, but not between Plc and
any ROTEM® CT results: see Fig. 2.
Fibrinogen, CRP and PIVKA-II
See Figs. 1 and 4. Mean fibrinogen levels increased
significantly, and although ROTEM® FIBTEM-MCF also
increased, it did not correlate to postoperative fibrinogen
concentration. There were weak significant correlations
between postoperative fibrinogen and both EXTEM-
MCF and EXTEM-CT but not FIBTEM-MCF: see Fig. 2.
Mean CRP increased significantly over the periopera-
tive course, and while both mean pre- and postoperative
PIVKA-II levels were greater than the manufacturer’s
reference range, postoperative values were significantly
greater than preoperative ones. There was no significant
correlation between PIVKA-II and PT-INR or CRP.
Of the 15 patients whose postoperative PT-INR was
equal to or greater than 1.2, the median postoperative
PIVKA-II was 8.2 mg/L. The patient with the highest pre-
operative PIVKA-II of 33 had impaired bile drainage due to
a stricture in ductus choledocus: bilirubin and ALP were
both elevated. PIVKA-II increased to 106 mg/L in this pa-
tient, but all other test results were within the normal
range. The patient who had been treated with warfarin until
5 days before operation also had biliary stasis and had an
elevated preoperative PIVKA-II of 25 mg/L, but this had
almost normalised to 6.8 mg/L when his epidural was with-






































































































Fig. 3 Boxplots show pre- to postoperative changes in platelet aggregometry (Multiplate®) and platelet count (Plc). Dashed lines indicate reference
intervals, brackets indicate significant differences between pre- and postoperative results *P < 0.05; **P < 0.01
Fig. 4 Boxplots show pre- to postoperative changes in PIVKA (protein induced by vitamin K absence), D-dimer, CRP and fibrinogen levels. Note
the lack of correlation between postoperative fibrinogen and ROTEM® FIBTEM-MCF. Note that two PIVKA outliers (106 and 398 mg/L) lie above
the axes’ limits. Dashed lines indicate reference intervals, brackets indicate significant differences between pre- and postoperative results
*P < 0.05; **P < 0.01
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received warfarin until 2 months before the operation had a
slightly elevated preoperative PIVKA-II of 2.8, which rose
to 5.4 mg/L postoperatively. One patient, operated for
stomach cancer, saw a dramatic rise in PIVKA-II levels
from 4.7 to 398 mg/L in the absence of other remarkable
test results.
Advanced coagulation test results
See Figs. 4 and 5. Mean FIX and FX concentrations
increased significantly over the perioperative period, espe-
cially FIX whose mean postoperative concentration
increased from to above its upper reference limit. Levels
of FXII and FXIII decreased significantly: preoperative
mean FXII was already below the reference interval, and
decreased significantly to 0.80 ± 0.33 kIE/L postoperatively
(reference range 1.07–1.50 kIE/L). Although factor XIII
levels decreased significantly, both the pre- and postopera-
tive mean levels were within the reference range.
Mean FII, FVII and FXI concentrations neither in-
creased nor decreased significantly pre- to postoperatively,
and their mean values were all within the reference ranges.
There were no highly significant strong correlations
between postoperative coagulation factor levels and other
test results. The following factors demonstrate weak sig-
nificant correlations to ROTEM® results: FII to FIBTEM-
MCF; FVII to EXTEM-CT, FIX to EXTEM-MCF, FX to
EXTEM-MCF, FXIII to EXTEM-MCF: see Fig. 2.
Discussion
Our results give some insight into the normal changes
in coagulation after major surgery, which is anything but
a normal condition for the body: Unfortunately, our
results do not allow us to come to a ‘blanket conclusion’
that patients are always hypercoagulable such that
routine tests can be ignored. The changes in coagulation
factors shown in this study do nevertheless provide some
tentative explanations for the elevated routine tests of
coagulation, and it would be reasonable to conclude that
the risk of hypocoagulation due to thrombocytopenia or
low levels of coagulation factors is greatest during the
first days after major operations, after which a systemic
inflammation and hyperfibrinogenaemia compensates
for potential deficits due to deficiencies in coagulation
factors and patients generally become hypercoagulable.
The incongruence between routine coagulation tests and
the other tests investigated in this study suggests that
slightly elevated PT-INR and aPTT are unlikely to repre-
sent serious coagulopathy.
PT-INR and aPTT’s tendencies towards hypocoagula-
tion are likely due to low levels of factors VII and XII,
respectively, and despite low postoperative levels of
factor XIII, whole-blood tests and Plc indicate normo-
or moderate hypercoagulation. This is in agreement with
previous work after hepatectomy by Louis et al. who
found the same discrepancy between PT-INR and
thrombelastography (TEG) and Elterman et al. who
found that after a transient period of hypocoagulability,
PT-INR stabilized around 1.3 from the fourth postopera-
tive day (Louis et al. 2014; Elterman and Xiong 2015).
Interpretation of coagulation factor activity is difficult
since their activities are interrelated: interactions rather
than absolute levels of coagulation factors ultimately
result in thrombin’s conversion of fibrinogen to fibrin
and most coagulation factors are not themselves used up
by coagulation. Changes in the concentration of individ-
ual factors do not therefore predictably increase or
decrease thrombin and fibrin generation. For example,
50 % changes in the concentrations of most vitamin
K-dependent factors were shown by Butenas et al. to
have little effect on thrombin generation, and an in-
crease in factor XI, which is required in the early stages
of the intrinsic coagulation pathway, actually decreased
thrombin generation if all other factor levels were
unchanged (Butenas et al. 1999). Similarly, isolated vari-
ations in the concentrations of vitamin K-dependent
factors II, VII and Z in warfarin-treated patients may































** * ** **
Fig. 5 Boxplots show pre- to postoperative changes in coagulation factor activities. Factors II, VII, IX and X are vitamin K-dependent. Dashed lines
indicate reference intervals, brackets indicate significant differences between pre- and postoperative results *P < 0.05; **P < 0.01
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have greater effects on both PT and thrombin generation
than other factors.
Acquired FXII deficiency explains elevated aPTT
The weak significant correlations between aPTT results
and levels of FII, FX, FXI and FXII are theoretically con-
sistent with these being factors involved in the intrinsic
pathway. Factor XII is required for activation of coagula-
tion, such that the low pre- and postoperative results
that we observed (see Fig. 5) may be responsible for the
prolonged aPTT. Synthesis of FXII is decreased by
systemic inflammation, explaining the negative correl-
ation between postoperative FXII and CRP (Citarella et
al. 1997). Even patients with a complete deficiency of
FXII do not have seriously dysfunctional coagulation
since FXI can be activated by FIIa: the substantial
increase in FIX seen in our patients ought to provide
additional compensation. We therefore question the
appropriateness of current guidelines’ insistence that a
‘normal’ aPTT is required for the safe withdrawal of an
epidural catheter in the absence of other risk factors for
haemorrhage (Gogarten et al. 2010; Breivik et al. 2010;
Horlocker et al. 2010b). On the other hand, aPTT may
be seen as a cheap and specific, yet insensitive, screening
for excessive accumulation of LMWH, even though we
actually saw no evidence of this in our patients—see
below (Thomas et al. 2015).
Acquired FVII deficiency may explain prolonged PT and
ROTEM® EXTEM-CT
The significant yet weak negative correlations shown
between FVII and both PT-INR and EXTEM-CT (see
Fig. 2) imply that decreases in FVII cause elevations of
these parameters: activation of FVII by exposure to
tissue factor is responsible for initiation of the extrinsic
pathway (Hoffman and Monroe 2001). Postoperative
FVII levels in the group as a whole were, however,
almost all within the reference interval and not quite sig-
nificantly lower than preoperative results (P = 0.07).
Previous work has shown that PT-INR is not elevated
until FII activity is less than 50 % of its normal level nor
is it a good predictor of clinical haemorrhage (Segal and
Dzik 2005); despite ROTEM® being frequently and
enthusiastically described as a global measure of coagu-
lation, Ninivaggi et al. found that it is unreliable in the
detection of therapeutic vitamin K antagonist activity:
in the context of this article, it would have low sensi-
tivity and high specificity for patients with coagulopathy
(Ninivaggi et al. 2014). Given that congenital deficiencies
of FVII cause clinical bleeding disorders and both PT-INR
and EXTEM-CT correlate to FVII activity in this patient
group, we suggest that it is inappropriate to withdraw an
epidural catheter when PT-INR or EXTEM-CT are above
the levels seen in this study. As vitamin K is relatively
non-toxic, we would recommend our current praxis of ad-
ministering vitamin K and delaying withdrawal of the
catheter until test results have normalized (Shearer 2009).
Fibrinogen levels and ROTEM® FIBTEM do not correlate
because of hyperfibrinogenaemia
An important finding in this study is that there was no
correlation between fibrinogen levels and thromboelasto-
metric measures of clot stability and that there was a
strong hyperfibrinogenaemia. This demonstrates that the
postoperative coagulative environment differs from that
during operations or haemorrhage: previous work has
found low FIBTEM-MCF to reflect low fibrinogen levels
(Schochl et al. 2011; Ogawa et al. 2012). We ascribe the
hyperfibrinogenaemia to inflammation caused by both the
operative insult and the patients’ pre-existing cancer
diagnoses (Cole et al. 2008; Fink-Neuboeck et al. 2016;
Battistelli et al. 2008) and suggest that it is the most import-
ant factor contributing to postoperative hypercoagulation.
Acquired deficiency of FXIII may be important and is
detected by thromboelastometry but not routine tests
Levels of FXIII decreased significantly over the periopera-
tive course and correlated significantly but weakly to
ROTEM® EXTEM and FIBTEM-MCF, which is in agree-
ment with previous preclinical and clinical studies: FXIII
stabilizes the fibrin clot. This stage of coagulation is not
detected by routine tests since it occurs after initiation
(Theusinger et al. 2010, 2013; Korte et al. 2009). Since our
ROTEM® results indicated postoperative hypercoagula-
tion, we suggest that low FXIII activity was compensated
for by the abundances of fibrinogen and platelets. Low
FXIII combined with low fibrinogen and platelets could,
however, constitute a dangerous coagulative environment
for withdrawing an epidural catheter that would not be
detected by PT-INR or aPTT. The lowest observed FXIII
level in our study was 0.38 kIE/L (38 % of normal) in the
patient who was also postoperatively thrombocytopenic.
One case series of 63 patients with acquired FXIII defi-
ciency presenting as clinical haemorrhage found FXIII
activity to be reduced between 0 and 58 % (Tone et al.
2016). FXIII deficiency should therefore be considered
before withdrawal of an epidural catheter in patients with
a clinical tendency to bleeding, particularly if thromboe-
lastometry indicates hypocoagulation.
We saw no evidence of accumulation of LMWH
ROTEM® results did not indicate that an accumulation
of LMWH could explain the elevated postoperative
aPTT values. In retrospect, we regret that we did not
measure anti-factor Xa activity as an additional test to
exclude heparin effect. ROTEM® INTEM and HEPTEM
can be used to detect heparin in vitro using blood from
healthy volunteers (Mittermayr et al. 2005), but we
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question these tests’ validity in the setting of our study
given that HEPTEM-CT was longer than INTEM-CT in
many of our patients. We had hypothesized that the
cause of accumulation of LMWH would be postopera-
tive relative renal failure, which would not appear to be
the case if we choose to believe that serum creatinine is
an accurate measure of renal function despite its sources
of error (Fliser 2008).
Platelets and platelet aggregometry
An additional explanation for the inconsistency between
routine and viscoelastic tests results is that routine tests
do not measure thrombocytosis or the increase in platelet
activity seen in this study. Coagulation factor-platelet
interactions, particularly in the context of activated
inflammation, are complicated: thrombin itself activates
intracellular pathways in platelets via the PAR-1 and PAR-
4 receptors and platelets bind to fibrinogen in the forming
clot such that apparent decreases in protein-mediated co-
agulation as shown by PT-INR and aPTT may be counter-
acted not only by hyperfibrinogenaemia but also platelet
hyperactivity (Franchi and Angiolillo 2015).
Is there a clinical role for platelet aggregometry when
deciding to remove an epidural catheter? Given the cor-
relation between Plc and Multiplate® results and that the
postoperative course is characterized by thrombocytosis,
we recommend screening with platelet count alone. Situ-
ations where platelet aggregometry would be appropriate
before withdrawing an epidural catheter include after
the administration of platelet inhibitors, for example
monitoring ticagrelor’s effect if it had been given because
of acute coronary syndrome; or if there was suspicion of
platelet dysfunction. Platelet function testing may also
be considered in clinical situations that are not following
a course of normal recovery: platelet function may be
abnormal after traumatic brain injury even in the pres-
ence of normal Plc (Nekludov et al. 2007).
PIVKA-II results suggest a deficiency of vitamin K which is
not consistent with the changes in coagulation factor
activity
PIVKA-II levels suggest that our patients had a pre-
operative deficiency in vitamin K which worsened over
the perioperative course, which is consistent with previ-
ous work from our own research group (Dauti et al.
2015). This is plausible since vitamin K requires bile for
absorption in the small intestine: all our patients had
pathology of the upper gastrointestinal tract. We note
that the normal preoperative albumin levels observed do
not suggest malnutrition, but also that albumin has a
low sensitivity and specificity for clinical malnutrition
and that many of our patients had lost weight (Covinsky
et al. 2002). There were no significant decreases in the
levels of activity of vitamin K-dependent coagulation
factor activities in the group as a whole (see Fig. 5): in
fact, FIX and FX actually increased significantly. We
were surprised that we did not see significant correla-
tions between PIVKA-II and any tests of coagulation or
CRP, other than FXII which actually showed a positive
correlation to PIVKA-II levels.
Previous work reaches conflicting conclusions regard-
ing the relationship between malnutrition, deficiency of
vitamin K and PT-INR. In one study, a week’s preopera-
tive fast resulted in prolonged postoperative PT and a
significant depletion of vitamin K-dependent clotting
factors (Moriwaki and Sugiyama 2010). In another study,
however, a low vitamin K diet 3 days before and after
surgery in patients undergoing non-hepatic gastrointes-
tinal surgery resulted in decreased levels of vitamin K,
without any effect on PT (Usui et al. 1990). We would
tentatively conclude that the patients in this study were
deficient in vitamin K but that the clinical relevance of
this is unclear. In addition to this, given that patients
with extremely elevated PIVKA-II were not hypocoagul-
able, we do not think that the PIVKA-II test that we
used can be used to identify patients who would benefit
from supplementation of vitamin K.
Conclusions
This study is novel in that we describe patterns of coagula-
tion in the specific context of withdrawing epidural cathe-
ters from patients with serious pathology of the upper
gastrointestinal tract and who have undergone major
surgery. Although PIVKA-II results suggested deficiency
of vitamin K, we could not demonstrate a clear correlation
between PIVKA-II results and deficits of vitamin
K-dependent coagulation factors. There is a clear discrep-
ancy between routine tests, which indicate a tendency
towards postoperative hypocoagulation which may be due
to postoperative decreases in factors VII and XII, respect-
ively, and thromboelastometry which indicates normo- or
hypercoagulability in the postoperative period, explained
by thrombocytosis and hyperfibrinogenaemia.
Can our results be used to make clinical praxis safer
and more evidence-based? Given the small size of this
study, we must be very cautious of drawing conclusions
that could affect patient care. First, testing for platelet
count remains mandatory due to the risk of transient
postoperative thrombocytopenia during the first few
days after operation and thereafter heparin-induced
thrombocytopenia due to treatment with LMWH. Sec-
ondly, the appropriateness of our praxis of administering
vitamin K to non-bleeding patients with slightly elevated
routine tests of coagulation can certainly be questioned
since normal postoperative thrombocytosis and hyperfi-
brinogenaemia appear to compensate for small relative
deficits in coagulation factors: it is clear from this and
other studies of postoperative coagulation, that patients
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who are recovering well after major surgery become
hypercoagulable after 3–5 days and that the aPTT and
PT-INR in the postoperative setting is generally some-
what higher than in healthy volunteers. Finally, can
viscoelstic tests be used to sort patients with mildly
elevated routine tests into those whose epidural can
safely be removed, and those where withdrawal should
be delayed or the coagulopathy treated? Due to throm-
boelastometry’s low sensitivity for moderate anticoagula-
tion with LMWH and vitamin K antagonists, and the
catastrophic nature of spinal haematoma, we would not
recommend using normal thromboelastometric results
as a carte blanche to ignore routine tests indicative of
coagulopathy. Nevertheless without being able to quan-
tify the risk/benefit ratio, we would feel confident with-
drawing an epidural catheter from a patient with a
PT-INR of 1.5 or aPTT slightly above the reference
range after the fourth postoperative day, provided that
the patient did not have thrombocytopenia, was recover-
ing well and had no clinical bleeding. It would be
imperative to withdraw the catheter following all the
usual caveats of the guidelines (Horlocker et al. 2010a;
Gogarten et al. 2010; Breivik et al. 2010).
We eagerly await new editions of guidelines for the
withdrawal of epidural catheters and expect that there
will be a tendency towards more aggressive monitor-
ing of coagulation during the early postoperative
period and a more relaxed attitude to screening with
PT-INR and aPTT in patients who are recovering
well and who do not have risk factors such as renal
failure or continued haemorrhage.
Limitations
This study should be seen as a pilot study examining
multifactorial relationships between several aspects
of coagulation and has therefore insufficient power
to exclude significant patterns. Even accredited tests
of coagulation are vulnerable to preanalytical error
(Kamal et al. 2007), but thromboelastometry and
platelet aggregometry in this study are particularly
prone to such errors since they were run by clini-
cians or medical students. In addition to this, as
with most studies investigating very rare complica-
tions, we were unable to measure any clinical end-
points: the risk of spinal haematoma is so low that a
prohibitively expensive multicentre approach would
be necessary to prospectively take blood tests from
patients with spinal haematoma. We are, however,
proponents of prospectively collecting blood samples
from patients who have been unfortunate enough to
have experienced a coagulative complication of neur-
axial blockade in order to run a full battery of
routine, whole blood and advanced coagulation tests.
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